DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...

Korea is a market with not only high medical standards but also very high interest in health and acceptance of new technology by global standards. That is why Dexcom, which leads the global continuous ...

Dexcom is already working on its G8 sensor for continuous glucose monitoring (CGM). But before you get too excited, the product is still a couple of years out, CEO Jake Leach told MD+DI during the J.P ...

Today, I'm going to talk about clinical concerns that I think both our patients and we have been having about sensors. First of all, there was a recall of some of the Freestyle Libre 3 Plus devices, ...

Abstract: This paper proposes miniaturized, lightweight and ultrasensitive planar metamaterial sensor for relative permittivity measurement of nondispersive materials. The proposed sensor is designed ...

When Dan Heller received his first batch of Dexcom’s latest continuous glucose monitors in early 2023, he decided to run a small experiment: He wore the new biosensor and the previous generation at ...

Stelo by Dexcom is a wearable glucose biosensor that brings continuous glucose monitoring into the consumer wellness space, aimed at adults who are not using insulin but still want detailed glucose ...

The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

A new scientific review reveals that the next decade of global agriculture will hinge on how quickly farmers, policymakers and technology developers can deploy advanced sensing systems across fields, ...

The latest research progress in the field of MXene-based neuromorphic computing is reviewed. The design strategy of MXene-based neuromorphic devices encompasses multiple factors are summarized, ...

New RAMQ coverage means eligible Québec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. Dexcom, ...